A2 Bio

A2 Bio Appoints James Robinson as New Chief Executive Officer and Member of the Board of Directors

Robinson to Lead Next Phase of Company’s Expansion and Pipeline Advancement March 25, 2024 09:00 AM Eastern Daylight Time AGOURA HILLS, Calif.–(BUSINESS WIRE)–A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to address the high unmet needs in cancer, today announced the appointment of James Robinson as its Chief Executive Officer and a member of its Board of Directors, … Continue reading A2 Bio Appoints James Robinson as New Chief Executive Officer and Member of the Board of Directors

CargoMetrics

CargoMetrics Launches Global Maritime Emissions Data Products

Maritime data analytics vanguard releases first of their kind emissions and fuel consumption products for benchmarking, monitoring, and carbon trading – conveniently available on AWS Data Exchange March 21, 2024 09:26 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–CargoMetrics, a global leader in the systematic monitoring and analysis of maritime trade, has announced the launch of new products that measure maritime emissions and provide trusted, unbiased data … Continue reading CargoMetrics Launches Global Maritime Emissions Data Products

Apollo Intelligence

Apollo Intelligence Wins 2024 Artificial Intelligence Excellence Award

With NLP and ML features in the Apollo Intelligence Next-Generation Platform for Market Insights, life science firms can gain significantly greater speed to insights and higher quality data March 20, 2024 09:00 AM Eastern Daylight Time WATERTOWN, Mass.–(BUSINESS WIRE)–Apollo Intelligence (Apollo), a leading provider of real-time data and insights to the healthcare and life science industries, was named a winner in the 2024 Artificial Intelligence Excellence Awards … Continue reading Apollo Intelligence Wins 2024 Artificial Intelligence Excellence Award

Enhanc3D Genomics

Enhanc3D Genomics appoints Dr Daniel Turner as Chief Scientific Officer

Appointment forms part of ongoing plans for continued development of the GenLink3D genomics platform and formation of strategic commercial and academic partnerships CAMBRIDGE, England–(BUSINESS WIRE)–Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D spatial genome for target and biomarker discovery, today announced the appointment of Dr Daniel Turner as Chief Scientific Officer (CSO). Dan’s deep expertise in genomics technology development and commercialisation will be … Continue reading Enhanc3D Genomics appoints Dr Daniel Turner as Chief Scientific Officer

Depixus

Depixus Appoints Steve Klose as Chief Commercial Officer to Drive the Commercialization of Its Groundbreaking MAGNA™ Technology

PARIS–(BUSINESS WIRE)–Interactomics pioneer Depixus has appointed experienced life sciences sales leader, Steve Klose, to the newly created role of Chief Commercial Officer from January 16, 2024. Klose will lead the company’s commercial growth strategy to build a highly effective sales and support organization, strengthening its market presence ahead of the commercial launch of its first laboratory instrument, MAGNA One™, in 2024. “I’m thrilled to have … Continue reading Depixus Appoints Steve Klose as Chief Commercial Officer to Drive the Commercialization of Its Groundbreaking MAGNA™ Technology